AAOI
Applied Optoelectronics, Inc.
AAOI has the edge over EGAN overall, supported by stronger modeled upside.
EGAN
eGain Corporation
EGAN has lower modeled downside risk, despite its lower overall score.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
EGAN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Unavailable |
EGAN's cash flow is currently strong, and its revenue and profitability are stable. There isn't enough data to rate its balance sheet.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
EGAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $4.11 | -33% |
| Current | 22x | $6.10 | — |
| Fair | 46x | $12.76 | +109% |
| Expensive | 67x | $18.84 | +209% |
Historical ranges are pointers, not guarantees.
EGAN's PE is 22x, but its earnings don't support one, so it isn't a reliable read right now.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
AAOI has the edge over EGAN on the outlook, with more favorable earnings and revenue expectations.
EGAN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect EGAN's earnings and profitability to decline, with its revenue holding steady.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI is still losing money, but far less than before: $0.42 per share over the past year, against $4.50 at its worst in late 2024.
EGAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.28 | -77% |
EGAN has the edge over AAOI in the latest year-over-year earnings comparison.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI has the edge over EGAN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI's operating margin was −0.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
EGAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21.9M | -7% |
| Q2 2026 | $22.2M | -4.7% |
| Q1 2026 | $22.5M | +7.1% |
| Q4 2025 | $23M | +2.6% |
EGAN's revenue has held roughly level: $22M last quarter, down 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.9% | -9.1 points |
| Q1 2026 | 8.9% | +8.8 points |
| Q4 2025 | 8.9% | +6 points |
| Q3 2025 | 12% | N/A |
| Q2 2025 | 14% | N/A |
| Q1 2025 | 0.1% | N/A |
| Q4 2024 | 2.9% | N/A |
EGAN has the edge over AAOI on profitability, with a higher operating margin.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
EGAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.3M | +$6.9M |
| Q1 2026 | -$1.9M | -189% |
| Q4 2025 | $9.9M | +57% |
EGAN and AAOI do not have enough comparable growth data to identify a winner.
AAOI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.7% | +6.3M shares |
| 1 year | +39% | +24.5M shares |
| 3 years | +168% | +55.1M shares |
| 5 years | +224% | +60.7M shares |
| Available history | +340% | +67.9M shares |
AAOI has 88M diluted shares, up 39% from a year ago.
EGAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -279K shares |
| 1 year | -2.8% | -789K shares |
EGAN has the edge over AAOI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $10.1M |
| Q1 2026 | — |
| Q4 2025 | $31,000 |
| Q3 2025 | $1.5M |
| Q2 2025 | $3.8M |
| Q1 2025 | $5M |
| Q4 2024 | $2.4M |
EGAN spent $12M buying back its own shares over the past year.
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EGAN Net Leverage
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
EGAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.7 | Neutral |
| Stochastic | 37.3 | Neutral |
EGAN's weekly RSI is 45 (neutral) and its Stochastic is 37 (neutral).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
EGAN PE vs Technology Sector
| Metric | EGAN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 28x | 22% below |
| PE % | 24 | 35 | 11 pts below |
EGAN is trading at 22x earnings, a 22% discount to the Technology sector's median of 28x, though its earnings don't support one.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has fallen below most of its moving averages, though it's still 43% above its 200-week average.
EGAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.78 | 5.5% above |
| 20 week MA | $6.25 | 2.4% below |
| 50 week MA | $7.74 | 21% below |
| 100 week MA | $7.43 | 18% below |
| 200 week MA | $7.09 | 14% below |
EGAN has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 14% below its 200-week average.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over EGAN on returns for 2026, with the stronger performance.
EGAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.11 | $12.6 | +55% |
| 2021 | $12.6 | $10.2 | -19% |
| 2022 | $10.2 | $8.85 | -13% |
| 2023 | $8.85 | $8.33 | -5.9% |
| 2024 | $8.33 | $6.29 | -24% |
| 2025 | $6.29 | $10.5 | +67% |
| 2026 YTD | $10.5 | $6.10 | -42% |
EGAN has finished lower in four of the last six years. It's down 42% so far in 2026.